EPAS1 and cancer: Whilethe relative contribution of each isoform to the survival and growthof tumors is dependent on multiple factors, including tumor type andstage of tumor, there is significant clinical evidence linking elevatedlevels of both HIF-1α and HIF-2α to poor patient outcomesin a wide variety of cancers.